Sinopharm Group Co., Ltd. is a distributor of pharmaceutical and healthcare products and a value added supply chain service provider in the People's Republic of China. The company is headquartered in Shanghai, Shanghai and currently employs 100,251 full-time employees. The company went IPO on 2009-09-23. The firm operates its business through four segments. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services to domestic and foreign pharmaceutical and health product manufacturers and other suppliers. The Device Distribution segment distributes medical devices to customers. The Pharmaceutical Retail Business segment owns a network of retail pharmacies that are directly operated or franchised. The Other Business segment is engaged in the manufacture and sale of pharmaceuticals, chemical reagents and laboratory supplies.
根据最新的财务报表(Form-10K),Sinopharm Group Co Ltd 的总资产为 $392,831,净利润为 $7,049
SHTDF 的关键财务比率是什么?
Sinopharm Group Co Ltd 的流动比率是 1.25,净利 margin 为 1.2,每股销售为 $187.3。
Sinopharm Group Co Ltd 的收入按细分市场或地理位置如何划分?
Sinopharm Group Co Ltd 最大收入来源是 Pharmaceutical Distribution,在最近的收益报告中收入为 460,322,005,211。就地区而言, China 是 Sinopharm Group Co Ltd 的主要市场,收入为 633,737,461,156。